August 15, 2024 at 12:53 pm

Cingulate (CING) Shares Skyrocket Over 150% on European ADHD Patent Announcement

PRISM Mental Health Index leader Cingulate (CING) saw shares rise over 150% on its recent news regarding the issuance of a European patent for its leading asset, CTx-1301 (dexmethylphenidate), designed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The biopharmaceutical company leverages its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop next-generation… [Read More]
August 15, 2024 at 11:38 am

Evolv (EVLV) Leads PRISM NextGen Tech and AI Index After Recent Security Patent Approval

Recently, Evolv Technology (EVLV), a pioneering company in AI-based security screening, was granted a significant patent by the United States Patent and Trademark Office (USPTO) for its innovative technology used in its flagship product, Evolv Express®. This cutting-edge system, designed to detect concealed weapons, is an integral part of safety plans in over a thousand… [Read More]
August 15, 2024 at 11:03 am

Biopharma Mover: OS Therapies (OSTX) Announces Q2 Earnings

Today the clinical-stage biopharmaceutical company OS Therapies (OSTX) announced Q2 earnings after its recent successful IPO that raised $6.4M on July 31, 2024. After IPO and preferred shares and debt conversion share issuances, there are 20.85 million common shares outstanding, with 1.86 million common shares available to be traded. As of the date of the… [Read More]
August 15, 2024 at 9:33 am

Stocks making the biggest moves premarket: Ulta Beauty, Walmart, Cisco Systems and more

Today’s Pre-Market Movers and Shakers Ulta Beauty’s shares ballooned a staggering 13% in premarket trading. This jump occurred in response to Warren Buffett’s Berkshire Hathaway acquiring a $266 million stake in the company during Q2. Walmart’s shares experienced a 7% surge due to remarkable earnings and revenue results, exceeding Wall Street’s expectations. The company anticipates… [Read More]
August 14, 2024 at 5:03 pm

New, more affordable EV from Chinese automaker, poses threat to U.S. auto industry: Watch out for Flocks of Seagulls

A newly available option from Chinese automaker BYD, the Seagull is a budget-friendly electric vehicle that may pose a significant threat to the U.S. auto industry. Priced at approximately $12,000, with a shorter-range version available for under $10,000, the Seagull stands out in the competitive global landscape of electric vehicles (EVs). Despite massive tariffs on… [Read More]
August 14, 2024 at 1:43 pm

NeuroBo Pharmaceuticals Leads PRISM Biotech Index with Q2 Cardiometabolic Milestones and $70M Funding Boost

NeuroBo Pharmaceuticals (NRBO) leads the PRISM Biotech Index after a strong Q2 2024 update. The company secured up to $70 million in financing, with $20 million upfront, to fund key milestones through Q2 2025. Highlights include the progress of DA-1726, an obesity treatment showing superior pre-clinical results, with Phase 1 top-line data expected in Q3… [Read More]
August 14, 2024 at 11:35 am

PRISM Economic Report: PPI and CPI Inflationary Indicators Slowing as Investors Await July Retail Sales on Thursday

This week market participants awaited inflationary indicator readings as Producer Price Index (PPI) and Consumer Price Index (CPI) reports were set to be released. Yesterday’s PPI report was released which measures inflation at the wholesale level and averages the change in prices domestic producers receive for their output. July’s PPI reading showed an increase of… [Read More]
August 13, 2024 at 4:27 pm

BioStem (BSEM) Reports Record Second Quarter Revenue of $74.5M with $116.4M Generated for the First Half of 2024

Advanced wound care technology company BioStem Technologies (BSEM) announced its second quarter financials and achieved a second consecutive record quarter for the company. BioStem reported $74.5M in revenue for the second quarter compared to $1M in 2023, which totaled first half revenue for the year to $116.4M. Gross profit was $70.7 million, or 95% of… [Read More]